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Abstract The importance of the construction of gene–gene
interaction (GGI) network to better understand breast
cancer has previously been highlighted. In this study, we
propose a novel GGI network construction method called
linear and probabilistic relations prediction (LPRP) and
used it for gaining system level insight into breast cancer
mechanisms. We construct separate genome-wide GGI
networks for tumor and normal breast samples, respec-
tively, by applying LPRP on their gene expression datasets
profiled by The Cancer Genome Atlas. According to our
analysis, a large loss of gene interactions in the tumor GGI
network was observed (7436; 88.7 % reduction), which
also contained fewer functional genes (4757; 32 % reduc-
tion) than the normal network. Tumor GGI network was
characterized by a bigger network diameter and a longer
characteristic path length but a smaller clustering coeffi-
cient and much sparse network connections. In addition,
many known cancer pathways, especially immune response
pathways, are enriched by genes in the tumor GGI network.
Furthermore, potential cancer genes are filtered in this
study, which may act as drugs targeting genes. These
findings will allow for a better understanding of breast
cancer mechanisms.
Keywords Gene–gene interaction  Network construction 
Breast cancer  TCGA dataset
1 Introduction
Breast cancer and many other malignancies result from
stepwise genetic alterations of cells [1, 2]. Over the last
decade, although the knowledge of specific genes and vari-
ous biological pathways of breast cancer has been revealed,
the understanding of breast cancer biology remains limited
[3, 4]. In fact, single genes or protein alterations are not
sufficient to induce cancer, but their interactions with other
genes or their surroundings play key roles [5–7]. Performing
network analysis using large-scale gene expression datasets
is an effective way to uncover new biological knowledge.
Network analysis has revolutionized our understanding of
biological processes and made significant contributions to
the discovery of disease biomarkers. Hence, to better
understand cancer pathogenesis, research from network
perspective is urgently needed [8–13].
Detecting pairwise interactions among genes plays basic
roles in the construction of GGI network. Many GGI pre-
diction methods have been proposed, including experimental
methods such as affinity purification [14] and yeast two-
hybrid assays [15], but such methods are generally in low
efficiency and high cost. Recently, calculation-based gene
correlation prediction methods incorporating gene expres-
sion datasets have been preferred [16, 17], such as Pearson’s,
Spearman’s and Kendall’s correlations, distance correlation,
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Hoeffding’s D measure, Heller–Heller–Gorfine measure,
mutual information (MI) [18] and maximal information
coefficient (MIC) [19]. Pearson’s correlation is the most
commonly used method for detecting linear relationships
among genes. For nonlinear or non-functional relationship,
rank correlation-based methods or information theory-based
measures are more applicable. MIC is based on the idea that
if a relationship exists between two random variables, then a
grid can be drawn on the scatter plot of the two variables [20].
However, gene expression data contain various types of
relationships, many of the methods only capture one type of
interaction (promotion or suppression). In this study, we
proposed a new GGI network construction approach termed
linear and probabilistic relations prediction (LPRP). LPRP
constructs GGI network in three steps: raw network con-
struction, expansion and revision. During each step, only
high-confidence gene interactions are considered, and a
backbone network is utilized. The complete human protein
interaction network from Pathway Commons [21] was used
as the backbone network topological structure, and only
interactions in the backbone network are kept to construct the
raw GGI network. Such methodological approach has been
proven fruitful in a variety of tumor genetic research fields
[10, 22–27]. LPRP detects both linear and probabilistic
relations among genes. In [28], the authors used a similar
method but did not consider reverse regulation. In addition,
we used a totally different gene interaction measure strategy.
In this study, we validate the effectiveness of LPRP
using both simulated and real gene expression and applied
LPRP on breast cancer data analysis. We construct separate
genome-wide GGI networks for tumor and normal breast
samples by applying LPRP on their gene expression data-
sets profiled by The Cancer Genome Atlas (TCGA). The
identification of global gene interaction perturbations that
actively participate in the initiation and maintenance of the
tumor state is a major challenge in cancer biology [29].
Over the last decade, specific cancer genetic alterations
have been well described and annotated [30], but network-
level research has rarely been conducted. In this study, we
performed a multi-level study (firstly, we compared the
difference between normal and tumor GGI network from
the gene-level, i.e., compare the difference between the
gene interactions. Secondly, we compared the modularity
difference between the constructed tumor and normal GGI
network, i.e., cluster-level. Finally, we compared the net-
work topology difference, i.e., network-level comparison).
It is known that functionally related genes tend to cluster
together in the biological network [31, 32]. Many network
clustering algorithms [33–35] are available in this area. In
this study, MINE [35] was used for cluster detection, as in
many previous studies [36], which can be easily done using
Cytoscape [37]. KEGG pathway enrichment analysis was
performed using the SIGORA R package under the default
parameter settings [38]. Furthermore, node degrees of
many known tumor genes were compared, and by mapping
known breast cancer genes to the tumor GGI network,
some potential cancer genes were filtered, which may act
as drugs targeting genes. Our findings allow for a better
understanding of breast cancer mechanisms and may have
potential implications for identifying novel drug targets.
2 Methods and Materials
2.1 Materials




e-tab.1.6.0/DESCRIPTION.txt for details of the RNA-
SeqV2 pipeline and the algorithms) gene expression data-
sets of 20,502 genes, including 120 breast cancer samples
and 106 normal samples, were downloaded from the
TCGA project webpage. Raw count values were normal-
ized using the TCGA-Assembler [40]. To further reduce
the error, genes with values of 0 across all samples were
deleted, leaving only 16,441 and 16,999 genes in the nor-
mal and tumor expression matrixes, respectively. The
complete human protein–protein interaction network was
downloaded from Pathway Commons (http://www.
pathwaycommons.org/), which was generated by bringing
together protein interactions from the following sources:
the Human Protein Reference Database (HPRD) [41], the
National Cancer Institute Nature Pathway Interaction
Database (NCI-PID) [42], the Interactome (Intact) [43] and
the Molecular Interaction Database (MINT) [44]. We
focused on non-redundant interactions, only including
proteins with an Entrez gene ID annotation, and isolated
nodes or edges were deleted. As a result, we obtained a
connected network with 15,589 nodes (unique Entrez IDs)
and 1896,352 documented interactions. Hereafter, we refer
to this network as the ‘‘KP’’. For comparison, two random
datasets were generated, and 237 known breast cancer-re-
lated genes were downloaded from SNP4Disease (http://
snp4disease.mpi-bn.mpg.de/result.php). After deleting
non-expressed genes, only 166 genes left. The gene
expression dataset and its benchmark networks of the
Dream5 challenge4 network inference challenge [45],
downloaded from (http://wiki.c2b2.columbia.edu/dream/
index.php?title=D5c4), were also used for comparison. To
do systematic evaluation, two datasets are used. One is a
real gene expression dataset contained in R package minet
[46]. The other is a simulated dataset simulated by SynT-
ReN (synthetic transcriptional regulatory network) [47]
which has 100 genes and 100 samples.
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2.2 Methods
LPRP takes the discretized matrix D (constructed later) and
KP as inputs and outputs the corresponding GGI network.
LPRP works in the following steps: First, the gene
expression matrix is discretized; second, gene interactions
are detected and statistically validated; and third, the GGI
network is constructed.
2.2.1 Discretization of Gene Expression Matrix
We denote the gene expression data matrix as M. For each
row of M, its average and standard deviation are calculated
as in [28]. We denote the average and deviation of the ith
row as avgi and sdi, respectively. D is defined by Eq. (1):
Dij ¼
1 if Mij\avgi  c sdi
0 if avgi  c sdi if Mij avgi þ c sdi





where c is the threshold value between 0 and 1.
We vary c from 0 to 1 in steps of 0.1. For each case, the
frequency distribution of the genes with respect to the counts
of 1, 0, -1 s in their profiles is shown in Fig. 1. As shown in
Fig. 1, when c takes a value between 0.4 and 0.5, the dis-
tribution that is most similar to the distribution of the ran-
domly generated discretized matrix and also has similar
distribution with those generated from currently commonly
used methods in ‘‘sdnet’’ R package (randomly generated of
0, 1 and -1) shown in Fig. 1. Hence, in this work, we used
c = 0.45 for the discretization of the gene expression matrix.
2.2.2 Gene Interaction Detection
Based on the discretized gene expression matrix D, for each
pair of genes in D under the same sample, only nine possible
value combinations exist. We represent one gene as gi and
another gene as gj; such combinations are shown in Eq. (2):
Cðgi; gjÞ ¼
ð1;1Þ where gi ¼ 1 and gj ¼ 1
ð1; 0Þ where gi ¼ 1 and gj ¼ 0
ð1; 1Þ where gi ¼ 1 and gj ¼ 1
ð0;1Þ where gi ¼ 0 and gj ¼ 1
ð0; 0Þ where gi ¼ 0 and gj ¼ 0
ð0; 1Þ where gi ¼ 0 and gj ¼ 1
ð1;1Þ where gi ¼ 1 and gj ¼ 1
ð1; 0Þ where gi ¼ 1 and gj ¼ 0























For each form of combination in Eq. (2), its probability




Dgi;h ¼ vi ^ Dgj;h ¼ vj
N
ð3Þ
where N is the sample number in matrix D, gi and gj are the
two genes as in Eq. (2), vi and vj take values from -1, 0, 1.
For simplicity, only three forms of interactions between
gi and gj are considered. That is, gi and gj are forward-
regulated, reverse-regulated or have no interaction. Fur-
thermore, we hypothesize that if gi and gj have a forward-
regulated relationship then their reverse-regulated power is
small or has no reverse regulation relationship between
them and vice versa. Furthermore, considering the per-
spective of entire network, only one form of regulation
dominates between the two genes, even though the other
form of regulation may sometimes exist. As a result, the
combinations in Eq. (2) can be classified accordingly.
Cð1;1Þ and Cð1; 1Þ are classified as the forward regu-
lation relationship (denoted as conðgi; gjÞ) but should fulfill
the restraints in Eq. (4), Cð1;1Þ and Cð1; 1Þ are clas-
sified as the reverse regulation relationship (denoted as
reðgi; gjÞ) but should fulfill the restraints in Eq. (5), and
other combinations such as Cð1; 0Þ;Cð1; 0Þ;Cð0; 0Þ;
Cð0;1Þ;Cð0; 1Þ are classified as no interaction relation-
ships or considered noise signals.
if conðgi; gjÞ then
 ððPð1;1Þ þ Pð1; 1Þ þ Pð0; 0ÞÞ  ðPð1; 1Þ
þPð1;1Þ þ Pð0; 0ÞÞÞ[ 0
 ððPð1;1Þ þ Pð1; 1Þ þ Pð0; 0ÞÞ  ðPð1; 0Þ
þPð0;1Þ þ Pð1; 0Þþ










if reðgi; gjÞ then
 ððPð1; 1Þ þ Pð1;1Þ þ Pð0; 0ÞÞ  ðPð1;1Þ
þPð1; 1Þ þ Pð0; 0ÞÞÞ[ 0
 ððPð1; 1Þ þ Pð1;1Þ þ Pð0; 0ÞÞ  ðPð1; 0Þ
þPð0;1Þ þ Pð1; 0Þþ










where in Eqs. (4) and (5), h is a threshold value between 0
and 1.
We varied h from 0 to 0.6 (according to our calculations,
no interactions exist when h[ 0.6) sin steps of 0.05, and
the corresponding numbers of gene interaction pairs, genes
(the number of gene of the random sample is not pre-
sented), Con regulations (forward regulation) and Re
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regulations (reverse regulation) detected from the tumor,
normal and random samples are presented in Fig. 2. h
varies from 0.1 to 0.6. Most interactions exist between 0
and 0.1, and when h[ 0.1, almost no interactions exist in
the random dataset. Therefore, we set h = 0.1 in this study
such that as many real gene interactions as possible can be
filtered.
We previously hypothesized that if genes gi and gj are
Con regulated then their Re regulation power under same
conditions should be small, as denoted in Eqs. (4) and (5).
Fig. 1 Frequency distribution
of -1, 0, 1 s in the discretized
matrix D and in the two random
matrices
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In fact, in real organisms, forward regulations are the most
common type of regulation, which is consistent with our
results, as shown in Fig. 2. As shown in Fig. 2, the number
of Con and Re interactions is almost equal in the random
samples, which again verified the validity of our method.
To further validate the effectiveness of our gene inter-
action detection strategy, gene expression datasets from the
DREAM 5 network inference challenge 4 were down-
loaded. After careful revision, we kept 104 samples con-
taining 5950 genes. The golden standard network of this
expression dataset was also downloaded, which contained
1994 genes and 3994 edges. The performance of the LPRP
was compared with the performances of Spearman, MI,
Kendall and MIC, and the results are shown in Fig. 3.
As shown in Fig. 3, the LPRP detected more known
edges compared to other methods, especially in the real
gene expression datasets. However, even with the LPRP of
the 3994 given edges in the Dream 5 network4, only 258
edges were detected out and of the 1,896,352 edges in KP,
and only 28,768 edges were detected out of the top
1,000,000 filtered edges. Therefore, gene interaction pairs
should not be used directly as the final edges for the net-
work construction; instead statistical validation and a net-
work construction strategy should be introduced to reduce
the false discovery rate.
2.2.3 Statistical Validation
To validate statistical significance of the GGIs identified by
the LPRP, for each gene in matrix D, the order of its value
(-1, 0, 1 s) across all samples was randomly shuffled. This
process was repeated 1000 times, this will allow matrix D
follows the same distribution as the original matrix. The
LPRP was applied on all of the 1000 randomized matrices
D, and each time only the interactions with interaction
values larger than 0.1 were filtered. First, we compared the
filtered GGIs number obtained from the real datasets and
the 1000 random datasets. Second, the proportion of GGIs
contained in KP was calculated. Higher proportions cor-
respond to increased LPRP effectiveness (as shown in the
results section, nearly four times more GGIs contained in
Fig. 2 Con and Re regulations,
gene number and interaction
number under different h values.
BRCA-T, BRCA-N and
Random represent the tumor,
normal and random samples,
respectively. Gene number is
the number of genes contained
in the filtered interactions,
interactions are sum of the Con
and Re interactions, Con
signifies the interactions that are
forward-regulated, and Re
denotes interactions that are
reverse-regulated
Fig. 3 Performance comparison of the LPRP and other methods
using both simulated and real datasets. ACCURACY is defined as the
number of known GGIs in the top 10,000, 100,000, 500,000 and
1,000,000 interactions. The top 10,000 is the number (10,000) of
GGIs filtered in each method under the given thresholds. a The result
based on the Dream5 network 4 datasets. b The result based on the
normal BRCA gene expression datasets. MIC is not included due to
its long running time
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KP were detected by the LPRP in the real dataset compared
to the random datasets). Third, because many more GGIs
are filtered with h[ 0.1 in the real datasets, how large the
possibility is if interactions satisfying h[ 0.1 while not
annotated by KP are novel activated interactions rather
than occurred by chance? To do this, the appearance times
of each such interaction are counted across all GGIs gen-
erated from 1000 randomized datasets. The p value is
defined as the proportion of appearance times to 1000
(Eq. (6)). Very few interactions had a p value [0.01.
Smaller p values correspond to lower probability of the
interaction occurring by chance. In this study, only GGIs
with a p value B0.01 were considered.
P value ¼ Tappear þ 1
1000
ð6Þ
where Tappear is the appearance time of one GGI in the
GGIs filtered from 1000 random datasets.
2.2.4 GGI Network Construction
After statistical validation, all interactions with h[ 0.1 but
p value [0.01 were discarded. Only interactions with
h[ 0.1 and a p value\0.01 were used for the GGI net-
work construction. The LPRP constructs the GGI network
in three steps: raw GGI network construction, expansion
and revision. The raw GGI network is constructed by using
interactions that satisfy the threshold value and also con-
tained in KP [21]. In this way, we can easily obtain a rough
topology of the final GGI network without introducing
much false positive gene interactions [39]. The gene
interactions in KP have no direction; therefore, gene gi
interacts with gj is equivalent to gj interacts with gi. If
either one exists in KP, we selected the edge from the
filtered GGIs (all the GGIs satisfy h[ 0.1 and p value
\0.01). With these raw GGIs, the expansion and revision
processes are executed alternatively until no edges remain
in all of the candidate GGIs. The purpose of expansion is
trying to add as much of edges left after raw construction as
possible to the raw network, while revision is preventing
expansion from introducing noise edges. In expansion, all
of the endpoint genes of the currently not added edges are
considered, and only genes that have direct interactions
with genes contained in the current GGI network are
attached to the current GGI network. Revision is performed
only between the newly added genes after the current
expansion stage. GGIs that satisfy the statistical validation
but that are not attached to the current GGI network can be
classified into the following three categories. (a) GGIs with
both endpoint genes already contained in the current raw
GGI network but not included in KP. We use Eq. (7) to
judge whether such GGIs should attach to the current GGI
network. In Eq. (7), Comnegðgi; gjÞ represents the common
neighbors of genes gi and gj. If their common neighbor
number is larger than the threshold value x, then we add an
edge between them; otherwise, they are left unconnected.
(b) GGIs with both endpoint genes not contained in the
current raw GGI network. For these GGIs, because it is
hard to determine whether they should be attached, we left
them as undetermined in the current cycle period. (c) GGIs
with only one endpoint gene included in the raw GGI
network. For these GGIs, we simply attached them to the
current GGI network. GGIs in (a) and (b) may correspond
to novel interactions or simply interactions that occurred
due to their common interacting neighbors. In revision
stage, we weigh whether those GGIs should be added or
discarded. As shown in Eq. (7), if their common neighbor
number is bigger than the threshold value, they are attached
to the current raw network. Otherwise, they are discarded.,
Comnegðgi; gjÞ[x ð7Þ
where Comnegðgi; gjÞ is the number of common neighbors
of genes gi and gj, and x is the threshold value. We set
x = 1 in this study (after the raw construction stage, all the
known GGIs have already been added to the network. The
main purpose of the expansion and revision is to add as
many edges as possible, because although these edges are
not contained in the know edge interaction datasets, they
all pass our statistic validation and are more likely to be
real existed interactions rather than occur by chance.
Hence, setting x at a smaller value is preferable.).
3 Results
Before applying LPRP on breast cancer datasets analysis,
effectiveness of LPRP is evaluated using both real gene
expression dataset and on simulated gene expression
dataset. Results are shown in Figs. 4 and 5.
As shown in Figs. 4 and 5, LPRP performs well on both
real and simulated gene expression datasets. Next, we
apply LPRP on breast cancer datasets analysis and con-
struct GGI networks of normal and tumor samples,
respectively. According to our analysis, we found that the
GGI network constructed from normal samples is a typical
complex network. Its node degree follows the power law
distribution, and its characteristic path length and network
diameter are 4 and 13, respectively, these values are 8.6
and 24 for the tumor GGI network, respectively. The tumor
GGI network contains fewer genes and gene interactions,
and its path length is longer. In fact, its path length follows
a normal distribution. Because a random mutation/alter-
ation in cancer is more likely to inactivate rather than
activate a gene, there is a large reduction in the number of
genes. Recent reports have also suggested that most genetic
mutations inactivate and affect tumor suppressor genes
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[45]. The node overlap between the two GGI networks is
large (56 % of the tumor nodes are found in the normal
GGI network), but only 18.4 % of the interactions present
in the tumor network are found in the normal network.
According to [46], cancer may be a pathway to cell sur-
vival, as in the tumor GGI network, new paths occurred
and new genes were activated, and these paths and genes
may play key roles in tumor initiation and development.
According to James West [10], cancers are characterized
globally by an increased network entropy, and the larger
the network entropy corresponds to the lower system sta-
bility. Increased network diameter and a decreased clus-
tering coefficient in the tumor network together foster such
instability.
Multi-level comparisons were performed between the
normal and tumor GGI networks. First, we compared the
networks from the entire network perspective, including
the differences in their network topology characteristics
and their common and particular genes and edges. Second,
clusters within the two networks were detected using
MINE, and their functions were annotated using the
SIGORA R [38] package and DAVID [47]. Third, the
characteristics of special genes (including genes particu-
larly expressed in tumor network, common network genes
that were differentially expressed, known breast cancer
genes) were compared.
3.1 Network-Level Comparison
By applying the LPRP on the tumor and normal BRCA
datasets with c = 0.45 and h = 0.1, 110,186 and 3,045,539
raw GGIs were filtered, respectively. After statistical val-
idation using a p value\0.01, only 102,688 and 2,893,901
GGIs remained for the subsequent GGI network construc-
tion, which contained 10,114 and 15,714 genes, respec-
tively. First, raw networks for both the normal and tumor
GGI networks were constructed, and then the expansion
and revision steps were alternately executed until no edges
could be added. Detailed information is provided in Figs. 6
and 7, and the supplemental file S1. All of the network
analyses were performed using Cytoscape [37, 48, 49].
3.2 Cluster-Level Comparison
Functionally related genes rarely work in isolation; rather,
they tend to form clusters and collaboratively perform
complex cellular functions. By detecting clusters in both
the normal and tumor final GGI networks, specific tumor
functional modules can be revealed. Many cluster detection
algorithms have been proposed, such as SPICi [50],
GECluster [51], MCODE [33] and MINE [35]. MINE
outperforms MCODE, SPICi and many other methods in
identifying non-exclusive, high modularity clusters and can
be easily run on Cytoscape software. MINE was run under
the default parameter settings. Seventeen clusters with their
node numbers greater than 5 of the tumor GGI network are
listed in Table 1. The cluster functions and their enriched
biological pathways were annotated using DAVID [47, 52]
and the R package of SIGORA. Pathways such as the P53
Fig. 4 Performance comparison of the LPRP and other methods
using syn.data real gene expression dataset (syn.data contained in
minet R package, syn.data includes gene expression dataset and
reference network). Panda [40, 41], Mrnet [42], CLR [43], ARACNE
[16] and mrnetb are GGI network inference methods, all can be found
in minet [44] R package
Fig. 5 Performance comparison of the LPRP and other methods
using simulated gene expression dataset (with 100 genes and 100
samples simulated by SynTren. SynTren can not only simulate gene
expression but also give reference network)
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signaling pathway, the cell cycle and the Jak-STAT sig-
naling pathway are well-known cancer pathways.
3.3 Gene-Level Comparison
The final tumor GGI network contained 4757 genes, 56 %
(2668) of which were also contained in the final normal
GGI network. The other 44 % genes may play important
roles in tumor progression. The enriched KEGG pathways
of the genes were analyzed using the R package of
SIGORA [38]. The top 25 pathways with a p value
\0.0008 are listed in Table 2. As shown in Table 2,
many pathways are well-known tumor pathways. Because
few genes and interactions are contained in the tumor
GGI network, most genes in the tumor GGI network have
less interacting edges compared to normal networks.
Through comparative analysis node degree of those
common genes, we found that most of them have same
neighbor numbers in both tumor and normal GGI
network; however, some genes have significant change in
their degree. In gene-level comparison, we filtered such
significantly changed genes and results were shown in
Fig. 6.
3.4 Potential Breast Tumor Gene Prediction
Next, we mapped the 166 (all genes are downloaded and
compiled from SNP4Disease website) known breast dis-
ease-related genes to the final tumor GGI network. These
genes and their neighbor genes were filtered out, and the
result is shown in Fig. 7. As shown in Fig. 7, breast genes
and their neighbor genes fall into three clusters. Because
genes within the same cluster tend to have similar func-
tions, we first annotated the three clusters using DAVID,
and the results are shown in Table 3. According to the
functional annotation results, many of these genes con-
tribute to cancer initiation and progression and may act as
potential breast cancer genes.
Fig. 6 Up- and down-regulated
gene node degrees in the final
tumor and normal GGI
networks. Normal indicates a
normal GGI network, tumor
indicates a tumor GGI network,
up degree gene indicates the
degree of genes was larger in
the tumor GGI network than in
the normal GGI network, and
down degree gene indicates that
the degree of genes was smaller
in the tumor GGI network than
in the normal GGI network
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Fig. 7 Breast disease genes and
their neighbors. In this figure,
known breast disease-related
genes are mapped to the final
tumor GGI network, and their
adjacent neighbors are filtered
out
Table 1 Functional annotation of clusters detected using MINE in the tumor GGI network
Cluster DAVID/SIGORA annotate Gene Benjamini p value
1 Ribosome, translational elongation 68 2.9E-125 1.1E-127
2 Cell cycle, P53 signaling pathway, DNA replication 73 9.5E-59 1.8E-61
3 Regulation of lymphocyte activation, regulation of leukocyte activation, immune response, T cell
receptor signaling pathway, Jak-STAT signaling pathway
39 1.9E-21 2.3E-24
4 Eextracellular matrix, proteinaceous extracellular matrix, cell adhesion, hydroxylation, extracellular
region
32 4.0E-36 4.4E-38
5 Immune response, apoptosis, regulation of apoptosis, response to virus 23 6.7E-9 3.3E-11
6 Mitotic cell cycle, chromosome, centromeric region, intracellular non-membrane-bounded organelle,
chemokine signaling pathway
16 8.4E-11 4.1E-13
7 Antigen processing and presentation of peptide antigen via MHC class I 12 1.5E-13 1.5E-13
8 Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, immune
response
8 1.4E-13 9.1E-16
9 IgG binding, alternative splicing 8 1.4E-8 1.5E-9
10 SH2 domain, chemokine signaling pathway 7 1.2E-4 2.4E-6
11 Protein biosynthesis, RNA transport 7 1.7E-4 1.8E-5
12 7
13 Chemokine signaling pathway, response to wounding, Cytokine-cytokine receptor interaction 6 1.7E-8 2.2E-10
14 Epidermis development, epithelial cell differentiation, ectoderm development 5 1.9E-7 6.8E-9
15 Immune response 5 2.6E-4 6.2E-6
16 Chemokine signaling pathway, NOD-like receptor signaling pathway, sh3 domain 5 1.7E-2 5.1E-4
17 Cell cycle, DNA replication 5 2.3E-6 3.8E-7
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4 Conclusion
In this study, both normal and tumor GGI networks were
constructed under the same parameter settings, and
multi-level comparisons are conducted. Results show that
the tumor GGI network has larger network diameter with
longer characteristic path length but a smaller clustering
coefficient and much sparse network connections, which
are different from those of normal GGI network. The
tumor GGI network contains fewer functional modules,
and many of them were enriched in known cancer-re-
lated pathways. Among the up-regulated genes, BRD7
encodes a protein that interacts with p53 and is required
for p53-dependent oncogene-induced senescence, which
prevents tumor growth. Among the down-regulated
degree gene, KIAA1967, also known as Deleted in
Breast Cancer 1 (DBC1), is a candidate tumor suppressor
gene involved in breast cancer [53, 54]. Finally, by
mapping known breast-related disease genes to the final
tumor GGI networks, three clusters were filtered out.
Because genes within the same cluster tend to have
similarly functions, genes within these clusters may be
potential breast cancer genes. These findings allow for a
better understanding of tumor mechanisms and may have
potential implications for the identification of novel drug
targets.
Table 2 KEGG pathway
enrichment analysis results
ID Pathway p value
1 Cytokine–cytokine receptor interaction 4.46E-200
2 Metabolic pathways 2.25E-34
3 Jak-STAT signaling pathway 3.24E-21
4 Protein processing in endoplasmic reticulum 1.18E-10
5 ErbB signaling pathway 8.19E-09
6 Amino sugar and nucleotide sugar metabolism 3.92E-06
7 Histidine metabolism 9.17E-06
8 Caffeine metabolism 1.05E-05
9 Glycerophospholipid metabolism 1.32E-05
10 Asthma 1.41E-05
11 Vitamin B6 metabolism 1.60E-05
12 Sulfur relay system 1.67E-05
13 Small cell lung cancer 2.35E-05
14 Cysteine and methionine metabolism 2.80E-05
15 Glycosphingolipid biosynthesis—lacto and neolacto series 3.14E-05
16 Fc gamma R-mediated phagocytosis 6.53E-05
17 Base excision repair 0.0001419
18 Synthesis and degradation of ketone bodies 0.0001611
19 Protein digestion and absorption 0.0001899
20 Porphyrin and chlorophyll metabolism 0.0002799
21 GnRH signaling pathway 0.0003071
22 Osteoclast differentiation 0.0004201
23 Alanine, aspartate and glutamate metabolism 0.0006986
24 Long-term potentiation 0.0007306
25 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 0.0007490
Table 3 DAVID annotation results of the three clusters in Fig. 7
Cluster DAVID Annotate Gene Benjamini p value
1 Extracellular matrix, cell adhesion, blood vessel development, EGF-like region, conserved site, cell
migration, pathways in cancer
77 1.0E-54 5.7E-57
2 Disulfide bond, transmembrane protein, Chemokine signaling pathway, inflammatory. Response,
immune response, apoptosis
62 1.3E-14 5.9E-17
3 Cell cycle, DNA repair, regulation of cell cycle process, pathways in cancer, apoptosis, immune
response
180 8.0E-41 2.7E-43
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